Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"B vitamin biosynthesis" is **not a single molecular target** but rather refers collectively to the diverse set of enzymatic pathways responsible for producing the water-soluble compounds known as the **B vitamins**. These include thiamine (B1), riboflavin (B2), niacin/nicotinamide (B3), pantothenic acid (B5), pyridoxine/pyridoxal/pyridoxamine (B6), biotin (sometimes called B7/B8), folate/folic acid (B9), and cobalamin/vitamin B12[2][5]. Each pathway involves multiple distinct enzymes and intermediates. In humans, most B vitamins must be obtained from diet because humans lack many key enzymes required for their de novo synthesis[5]. Some bacteria and plants can synthesize all or most of these compounds through well-characterized biochemical routes[1][3][4]. The term "B vitamin biosynthesis" is therefore **too broad and non-specific** to serve as a canonical therapeutic target. Instead, research often focuses on specific enzymes within an individual pathway—such as dihydropteroate synthase in folate synthesis—as drug targets. Because this entry does not refer to any one molecule/protein/receptor/enzyme/transporter/etc., it should be flagged as incorrect if used where a precise molecular target is required. Key points supporting 'is_incorrect': * The term describes multiple unrelated metabolic processes rather than one defined molecular entity. * There is no standard abbreviation. * It cannot be classified under typical molecular families like enzyme/receptor/transporter. * No drugs act on "all" B-vitamin synthetic processes at once; interventions are always at the level of specific steps/enzymes. (Note: some antibiotics may inhibit specific enzymes within individual vitamin pathways, not the entire process as one target) * Biomarkers/safety issues pertain only to deficiencies/excesses in particular vitamins. For structured data extraction purposes, this entry should be replaced with more precise targets such as “Dihydropteroate synthase” for folate synthesis inhibition or “Cobalt chelatase” for cobalamin production inhibition[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on B vitamin biosynthesis.